药物涂层支架的研究进展  

Progress on Drug-eluting Stents

作　　者：王向真[1] 李丹[1] 安毅[1] 

机构地区：[1]青岛大学附属医院心内科,山东青岛266100

出　　处：《心血管病学进展》2014年第6期707-711,共5页Advances in Cardiovascular Diseases

摘　　要：冠状动脉支架的应用极大地降低了再狭窄率,使经皮冠状动脉介入治疗有了质的飞越。冠状动脉支架发展至今已多种多样,其中药物涂层支架应用最为广泛,但药物涂层支架在降低支架内再狭窄的同时存在增加支架内血栓的风险。因此,不断改进药物支架是目前的研究热点,且药物支架向可降解支架逐渐发展。现就主要的药物涂层支架进行综述,介绍药物涂层支架的发展过程并大胆预测其发展趋势。The use of coronary stents have greatly reduced the rate of restenosis. Drug-eluting stents are widely used in patients with coronary heart disease. However, their usage increases the risk of stent thrombosis while reducing in-stent restenosis. Therefore, studies are focused on continuing to improve drug-eluting stench. This summary tracks major developments in drug-eluting stents.

关 键 词：冠心病 药物涂层支架 可降解支架 

分 类 号：R318.08[医药卫生—生物医学工程]